Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa
The CRISPR Journal · 01.04.2026 · 9 (2) · 59-70
DOI: 10.1177/25731599261424870 ↗Kurz gefasst
Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 02.04.2026. Verfasst von Sarah K Topfer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health & Biosecurity, Acton, Australia. Hauptthemen laut MEDLINE: Spermatozoa, Transfection, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 67 Literaturangaben.
Abstract (Originalsprache)
Modern genome editing tools such as CRISPR-Cas9 have revolutionized mammalian genome engineering, yet translation to in vivo applications remains limited by low efficiency and frequent occurrence of mosaicism. Sperm-mediated delivery of editing reagents is one proposed alternative that may mitigate these issues. This method depends on efficient transfection of genome editing materials into viable spermatozoa, a critical yet frequently overlooked parameter. Using FACS, we compared electroporation (Neon NxT) and lipofection (CRISPRMAX) for introducing CRISPR-Cas9 ribonucleoproteins into viable rabbit spermatozoa. Electroporation, shown to enable Cas9 and plasmid transfection in spermatozoa from other species, performed poorly once dead spermatozoa were excluded. In contrast, Lipofectamine CRISPRMAX improved transfection efficiency with minimal effects on spermatozoa viability and motility. These findings emphasize the importance of distinguishing true transfection (transfection of viable spermatozoa) from total transfection and highlight lipofection as a promising alternative to electroporation for sperm-based genome editing, with potential applications in rabbit genome engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health & Biosecurity, Acton, Australia.
Zitieren
APA
Topfer, S. K., Rutherford, M., Zewe, F., Strive, T., & Oh, K. P. (2026). Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa. The CRISPR Journal, 9(2), 59-70. https://doi.org/10.1177/25731599261424870
Vancouver
Topfer SK, Rutherford M, Zewe F, Strive T, Oh KP. Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa. The CRISPR Journal. 2026;9(2):59-70. doi:10.1177/25731599261424870
BibTeX
@article{Topfer2026,
author = {Topfer, Sarah K and Rutherford, Madi and Zewe, Frances and Strive, Tanja and Oh, Kevin P},
title = {Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa},
journal = {The CRISPR Journal},
year = {2026},
volume = {9},
number = {2},
pages = {59--70},
doi = {10.1177/25731599261424870}
}
EUVIMED